tiprankstipranks
Trending News
More News >
Pacific Radiance Ltd. (SG:RXS)
SGX:RXS
Singapore Market

Pacific Radiance Ltd. (RXS) AI Stock Analysis

Compare
5 Followers

Top Page

SG:RXS

Pacific Radiance Ltd.

(SGX:RXS)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
S$0.12
▲(28.89% Upside)
The score is driven most by attractive valuation (low P/E and very high dividend yield). Financial performance is solid due to strong profitability and improved leverage, but it is held back by negative free cash flow. Technicals are supportive with price above key averages and positive MACD, though RSI near overbought limits the technical score.
Positive Factors
Strong revenue growth
A 39.6% revenue jump signals durable demand expansion and contract wins in offshore services. Sustained top-line growth supports scale benefits, improves unit economics and funds reinvestment into fleet and services, strengthening competitive position over the medium term.
High operating and profitability margins
Exceptionally high EBIT/EBITDA and net margins indicate structural operating efficiency and pricing power in niche marine/offshore services. Such margins provide buffer against cyclical revenue swings and enable internal funding for maintenance, dividends or selective growth over coming quarters.
Low leverage and strong ROE
A very low debt-to-equity ratio combined with 32% ROE implies prudent capital structure and effective use of equity to generate returns. This reduces refinancing risk and preserves strategic optionality for fleet investment or contract-backed expansion over the medium term.
Negative Factors
Negative free cash flow
Negative free cash flow despite strong reported earnings weakens financial flexibility: it restricts the company’s ability to self-fund capex, service unexpected costs or sustain distributions without external financing, creating a persistent liquidity vulnerability.
Decline in gross profit margin
A falling gross margin signals rising direct costs or pricing pressure at the service level. If persistent, this erodes the foundation of high operating margins and could require structural changes—cost control, pricing renegotiation or mix shifts—to preserve long-term profitability.
Weak cash conversion quality
OCF-to-net-income of 0.59 and negative FCF growth imply reported profits are not fully converting to cash. This raises concerns about earnings quality and the sustainability of investments or payouts, increasing the chance of reliance on external funding or asset sales.

Pacific Radiance Ltd. (RXS) vs. iShares MSCI Singapore ETF (EWS)

Pacific Radiance Ltd. Business Overview & Revenue Model

Company DescriptionPacific Radiance Ltd. (RXS) is a leading provider of integrated marine and offshore support services, specializing in the oil and gas industry. The company operates a fleet of vessels that offer a range of services including offshore support, subsea services, and marine logistics. With a strong focus on safety and efficiency, Pacific Radiance serves clients across various sectors, ensuring reliable and innovative solutions tailored to the demands of the energy market.
How the Company Makes MoneyPacific Radiance Ltd. generates revenue primarily through the provision of marine support services to the offshore oil and gas industry. The company's revenue model is multifaceted, with key revenue streams including chartering of specialized vessels, providing subsea services, and offering logistical support for offshore operations. Additionally, Pacific Radiance engages in long-term contracts with major oil and gas companies, ensuring a steady income flow. Partnerships with industry leaders and participation in joint ventures further enhance their service offerings and market reach, contributing significantly to their earnings. The company also explores opportunities in emerging markets and diversifies its service portfolio to adapt to changing industry demands.

Pacific Radiance Ltd. Financial Statement Overview

Summary
Income statement strength (revenue growth 39.6%, high net/EBIT/EBITDA margins) is tempered by weaker cash flow quality (negative free cash flow and negative FCF growth) and a noted decline in gross margin.
Income Statement
75
Positive
Pacific Radiance Ltd. has shown a strong revenue growth rate of 39.6% in the latest year, with a solid net profit margin of 58.97%. The EBIT and EBITDA margins are also robust at 56.05% and 66.78%, respectively, indicating efficient operations. However, the gross profit margin has decreased compared to previous years, suggesting potential cost management issues.
Balance Sheet
65
Positive
The company has significantly improved its debt-to-equity ratio to 0.09, indicating reduced leverage and improved financial stability. The return on equity is strong at 32.33%, reflecting effective use of equity to generate profits. However, the equity ratio is not provided, limiting a full assessment of asset financing.
Cash Flow
50
Neutral
The operating cash flow to net income ratio is moderate at 0.59, showing decent cash generation relative to net income. However, the free cash flow is negative, and the free cash flow to net income ratio is -0.29, indicating challenges in generating free cash flow. The free cash flow growth rate is also negative, pointing to potential liquidity issues.
BreakdownDec 2024Dec 2024Dec 2023Dec 2023Dec 2022
Income Statement
Total Revenue43.84M31.41M
Gross Profit14.31M12.54M
EBITDA29.28M19.70M
Net Income25.85M14.52M
Balance Sheet
Total Assets115.76M108.13M
Cash, Cash Equivalents and Short-Term Investments17.83M26.72M
Total Debt7.01M38.28M
Total Liabilities35.96M70.42M
Stockholders Equity79.96M37.87M
Cash Flow
Free Cash Flow-4.47M4.09M
Operating Cash Flow15.56M8.92M
Investing Cash Flow-19.87M-4.83M
Financing Cash Flow-2.32M-3.15M

Pacific Radiance Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.11
Negative
100DMA
0.10
Negative
200DMA
0.08
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
35.69
Neutral
STOCH
-12.82
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:RXS, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.11, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 35.69 is Neutral, neither overbought nor oversold. The STOCH value of -12.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:RXS.

Pacific Radiance Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
S$70.67M1.495.32%348.53%-86.29%20.88%
71
Outperform
S$152.81M4.150.49%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
S$59.56M9.6628.37%2.11%-4.17%-54.26%
61
Neutral
S$319.00M20.950.78%
48
Neutral
S$34.71M13.8111.84%30.68%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:RXS
Pacific Radiance Ltd.
0.10
0.06
155.00%
SG:1V3
Mooreast Holdings Ltd.
0.13
0.02
21.82%
SG:5UL
Atlantic Navigation Holdings (Singapore) Ltd.
0.13
0.09
197.67%
SG:A04
ASL Marine Holdings Ltd.
0.30
0.24
400.00%
SG:BEZ
Beng Kuang Marine Ltd.
0.29
0.05
23.91%
SG:WPC
Vallianz Holdings Limited
0.06
0.03
64.10%

Pacific Radiance Ltd. Corporate Events

Leadership Transition at Pacific Radiance Ltd.
Nov 7, 2025

Pacific Radiance Ltd. has announced the resignation of its Chief Strategy and Business Development Officer, Mr. Pang Wei Kuan, James, effective from November 10, 2025. The company acknowledges his significant contributions, particularly in fostering new business opportunities. The responsibilities of the role will be assumed by the Chief Commercial Officer, Mr. Pang Wei Meng, to ensure continuity in strategic and business development initiatives. The Board remains confident that these changes will support the company’s strategic objectives and facilitate continued growth, with a smooth transition to maintain business momentum.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 31, 2025